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ABSTRACT
Background: Ankylosing spondylitis (AS) is a chronic,
potentially crippling, spondyloarthropathy with strong
genetic components affecting approximately 0.3% of the
population. Its exact genetic mechanism and mode of
transmission, however, remains obscure.
Methods and results: The authors conducted a genome
wide scan on 75 individuals across multiple generations of
three Han Chinese families affected with AS. Segregation
analysis and pedigree investigation suggested an auto-
somal dominant inheritance. Pairwise logarithm of odds
(LOD) scores were calculated using LINKAGE package for
the obtained genotypes. High resolution mapping was
then performed based on markers with significant LOD
scores. To minimise the number of crossovers in each
family, haplotype were constructed and assigned. Two of
the pedigrees shared one candidate region for AS on
2q36.1–2q36.3 spanning 6-cM (maximum heterogeneity
LOD score of 12.41 at marker D2S2228), while the other
showed strong linkage to the HLA-B region.
Conclusions: This is the first report which proposes one of
thenewgenetic modelsofautosomal dominanttransmission
in AS. The breakthrough in the identification of linkage to
chromosome2q36.1–2q36.3andtheHLA-Bregionhighlights
thefuturepotentialofmorecomprehensivegeneticstudiesof
determinants of disease risk.
Ankylosing spondylitis (AS; MIM 106300) is a
chronic, debilitating, inflammatory disorder that
primarily affects the axial skeleton and frequently
involves the peripheral joints, the attachments of
ligaments and tendons to joints (the entheses), and
also extra-articular structures. The overall preva-
lence of AS in the world population has been
reported to be 0.2–0.9%.
1 In the Chinese popula-
tion, the pooled prevalence is not much different,
and has been reported to be around 0.2–0.4%.
2
The precise cause of AS is still unclear. The
aetiology of the disease is predominantly deter-
mined by genetic factors, and environmental
factors also play a role. Previous twin based studies
estimate that disease heritability exceeds 90%.
3
The recurrence risk ratio for siblings (ls) of AS
has been reported to be as high as 82.
4 A consistent
strong linkage to chromosome 6, including the
HLA-B region, has been recognised for decades.
Among the Asians, 5–10% of the population is B27
positive. Yet, only 1–5% of these B27 positive
individuals develop AS. B27 can explain no more
than 30% of the overall genetic risks of AS.
5 The
mechanistic hypotheses of B27 causing AS are also
not well established.
6 Recently, two new loci
related to AS, aminopeptidase regulator of
TNFR1 shedding 1 (ARTS1) and the interleukin
23 receptor (IL23R), were independently reported
in a North American cohort by 14 436 non-
synonymous SNPs (nsSNPs) screen, confirming
an AS related genetic disorder outside HLA-B27
through case–control association study.
7
Genome-wide linkage scans have also implicated
several additional loci outside the major histocom-
patibility complex (MHC) region.
8–10 The decoding
of the molecular aetiology of AS is contingent on
the identification and characterisation of these
non-MHC susceptible genes.
SUBJECTS AND METHODS
Subjects and ascertainment of the pedigrees
Peripheral blood samples were obtained from a total
of 75 individuals (25 AS patients and 50 unaffected
subjects) representing three to four generations of
three large Han Chinese families affected with AS.
Each patient was assessed by at least two qualified
rheumatologists, and the diagnosis was made
according to the 1984 modified New York criteria
of AS.
11 Subjects were defined as unaffected indivi-
duals if they had no evidence of AS related clinical
manifestations and radiographic or magnetic reso-
nance imaging changes. Informed consent was
obtained from each subject enrolled into the study.
The approval of the local ethical committee was also
obtained before initiating the study.
Segregation analysis
Beforethemodel basedgenome wide linkage analysis
of the three pedigrees with AS, segregation analysis
was performed to investigate the presence of major
type effects and segregation patterns within the
pedigrees using the SAGE program SEGREG for
binary phenotypes.
12 Regressive multivariate logistic
models for binary traits were used to investigate the
segregation pattern within the pedigrees.
13 In this
model,the marginal probability (calledsusceptibility)
thatanypedigreememberhasaparticularphenotype
i st h es a m ef o ra l lm e m b e r sw h oh a v et h es a m e
values of any covariates in the model and is given by
the cumulative logistic function:
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affected individual and 0 for an unaffected individual; and hii s
the logit of the susceptibility for the ith individual, which
depends on the major type (u=AA or AB or BB) and covariates
xi1, xi1,…, xip:
The nuclear familial residual association parameter (r), which
is analogous to the correlation parameter in regressive models
for continuous traits,
14 is a second order correlation and is
incorporated into the models to account for residual polygenic
and common environmental effects. We assumed no spouse
correlation and equal parent–offspring and sib–sib correlation
throughout the analyses. Ascertainment bias was corrected by
modelling the simplex sampling scheme from which the
pedigree was recruited. Hypotheses were assessed by the
likelihood ratio test, under the assumption that the negative
of twice the difference in natural logarithms for hierarchical
models follows a x
2 distribution.
15
DNA extraction and genotyping
Genomic DNA was extracted from venous blood according to
established protocols.
16 Genome-wide scans were performed on
pedigree A and C. Genome-wide scans using 382 fluorescent
microsatellite markers (ABI Prism Linkage Mapping Sets,
Version 2.5) located on all autosomes were performed.
Genotyping was performed on an Applied Biosystems (ABI)
3700 automated DNA sequencer. Each multiplex PCR reaction
was performed according to standard instructions. Gene mapper
3.0 (Applied Biosystems, Foster City, California, USA) was used
for data collection and microsatellite allele analysis. All
genotypes were checked for Mendelian segregation in pedigrees.
Linkage analysis
We conducted both parametric and non-parametric linkage
analysis in all three pedigrees (A, B, and C). For parametric
linkage analysis, pairwise two-point (logarithm of odds) LOD
scores were calculated using the LINKAGE package. An
autosomal dominant model was assumed and, in view of the
prevalence of the disorder, the frequency of the abnormal allele
was set at 0.003 with an assumed penetrance.
12 Allele
frequencies for the microsatellite markers were set at 1/n (n=
number of alleles). The recombination frequency (h) was stated
as equal for both sexes. Heterogeneity LOD (hLOD) scores were
computed by combining results per family with use of standard
formulas HLOD=log10 (maxLR), where maxLR is maximised
with respect to a, the proportion of the linked families, yielding
maximum likelihood estimate.
High resolution mapping
High resolution mapping was performed in all three pedigrees
(A, B and C). Marshfield markers were selected according to
marginal negative markers with priority given to marker
heterozygosity based on the initial genome scan results. We
constructed and assigned the shared haplotype in families for
potential region.
RESULTS
The distribution of affected AS patients among the three
pedigrees and their family structure are shown in figs 1 and 2. In
the 25 AS patients of the 3 families, 15 are male and 10 are
female (male: female ratio 3:2). The disease duration (mean
(SD)) is 9.82 (5.80) years. The onset age (mean (SD)) is 22.45
(6.21) years, ranging from 9–31 years. In clinical manifestations,
all patients have sacroiliac and spinal involvement. Among
them, nine patients had peripheral joint involvement and 12
patients had enthesitis in three families, respectively. In family
A, three patients had hip involvement. None of the affected
individuals had a history of uveitis.
Complex segregation analysis was employed to investigate
the inheritance pattern within the pedigrees. Parameter
estimates for six different models of family C are shown in
the table 1.
The null hypothesis of no major gene effect was assessed by
comparing the model containing multifactorial inheritance alone
(H01: qA=1) with that containing both a Mendelian major gene
and multifactorial inheritance (HA1: 0,qA,1; tAA=1.0,
tAB=0.5, tBB=0.0). The model with both effects has three
additional parameters (qA and two susceptibilities), so the
likelihood ratio statistic (x
2) has three degrees of freedom (df).
Figure 1 Family structure of pedigree C.
Star mark represents individuals with
collected DNA samples conducted in
genome wide scan and fine mapping. No
star mark represents individuals without
collected DNA samples who were
unwilling to donate their blood. The
proband is marked with an arrow.
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tested by comparing the commingled model (H02:
qA=tAA=tAB=tBB) with the model in which all transmis-
sion probabilities were estimated (HA2: qA?tAA?tAB?tBB,
3 df). The null hypothesis of Mendelian transmission was
tested by comparing the mixed Mendelian model (H03:
tAA=1.0, tAB=0.5, tBB=0.0) with a model where all
transmission probabilities were estimated (HA3: free t’s, 3 df).
The null hypothesis of dominant Mendelian inheritance (H04)
was tested by comparing the model of the mixed Mendelian
model (the general model) with the mixed model
(SuscAA=SuscAB?SuscBB, 1 df). The null hypothesis (H05:
SuscAA?SuscAB=SuscBB) of recessive Mendelian inheritance
was tested insimilar way. Infamily C, the hypothesis of no major
effect was rejected (x
2=20.78, df=3, p=1.17610
24), and the
hypothesisofnotransmissionofthemajoreffectwasalsorejected
(x
2=9.79, df=3, p=0.02). As expected, the hypothesis of
Mendelian transmission was not rejected (x
2=4.02, df=3,
p=0.26). Both dominant and recessive Mendelian inheritance
models were not rejected with p=0.81 and 0.19, respectively.
Figure 2 Shared haplotype of family A
and B. Marker haplotypes on
chromosome 2q36.1–2q36.3 that are
linked to ankylosing spondylitis (AS) are
indicated by black bars. Marker positions
were obtained from Marshfield (http://
research.marshfieldclinic.org/genetics/
GeneticResearch/compMaps.asp).
Microsatellite markers are listed at left
from centromere to telomere (top to
bottom). The proband was marked with
an arrow. Haplotypes were interpreted by
minimising recombinants. In each
haplotype pair, paternal haplotype is to
the left and maternal to the right.
Original article
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major gene was segregating in the large and extended pedigree
in the manner of autosomal dominant Mendelian inheritance.
In family A and B, the hypothesis of no major effect was not
rejected (x
2=3.97, df=3, p=0.27), but both the hypothesis of
dominant and recessive Mendelian inheritance models were not
rejected with p=0.44 and 0.35, respectively. This discrepancy
between the three tests might due to the fact that the two
models for H01 are not hierarchical with each other and thus
the test for H01 is less powerful, although such a test was
extensively used in the segregation analysis. The results of the
later two tests clearly support the conjecture that a putative
major gene was segregating in these two pedigrees, and maybe it
is more likely to be segregating in the manner of autosomal
dominant Mendelian inheritance. All the LOD scores were
evaluated at recombinant fraction from 0.0 to 0.4 with the
penetrance from 0.56 to complete penetrance (LOD scores
calculated with the penetrance of 0.56 based on our segregation
analysis result of family C are shown in table 2).
Parametric linkage analysis was performed for the three
pedigrees for the autosomal recessive model with the assumed
penetrance derived from segregation analysis to complete
penetrance, and the recessive inheritance model was excluded
based on the unfavourable two-point LOD scores in the tests.
Initial analysis data using LINKAGE revealed a positive
linkage LOD score of 2.28 at marker D2S126 (h=0) in family
A, while a negative LOD score of 24.72 at this marker was
obtained in pedigree C. Additional markers within 10 cM
around marker D2S126 (221.13 cM) from the Marshfield
website were selected to extend fine mapping in pedigree A
and B (fig 3). The heterozygosity of these markers and LOD
scores and heterogeneity LOD scores of the families A and B,
targeted in the shared region, are available in table 2. By
analysing individuals in which recombination had occurred in
both families, we narrowed the region to a 6 Mb region on
2q36.1–2q36.3 between markers D2S377 and D2S1349 (fig 2).
The maximum heterogeneity LOD score in pedigree A and B
reached 12.41 (family A maximum LOD score is 3.26 and family
B maximum LOD score is 2.13) at marker D2S2228.
Based on linkage to chromosome 6 at marker D6S422 (LOD
1.76, h=0) in initial genome scan in pedigree C, we selected five
Marshfield markers located between 42.27 cM and 50.75 cM
around the HLA-B region, including D6S2439, D6S273,
D6S1666, D6S1583 and D6S1051, to extend fine mapping in
pedigrees A, B and C. In pedigree C, the highest LOD score 4.02
was obtained at D6S273 (h=0). In pedigree A, the highest LOD
score 2.67 was obtained at D6S1583 (h=0). In pedigree B, no
linkage was observed for these fine mapping markers.
DISCUSSION
The inheritance mode of AS tested by sibling recurrent risk
studies has been considered as oligogenic and multiplicative
interaction among loci.
4 Epidemiologic studies suggested a non-
sex linked dominant heredity involvement,
17 but until now no
affirmative mode of inheritance has been proposed. Although
AS has been widely considered to be a multifactorial genetic
disease with a well accepted knowledge of linkage to the MHC
loci, its role in the pathogenesis of AS has not been well
established and existing studies revealed evidence of non-MHC
loci. Meanwhile, subjects in previous genome wide scans
conducted in western countries were mainly affected sib pairs
(ASM) or nuclear families, without multi-generational large
pedigrees recruited. In the present study, we have described for
the first time that a new form of AS inheritance mode is
autosomal dominant, based on not only pedigree investigation
and segregation analysis, but also parametric linkage analysis
with genome scans and fine mapping in these families. Among
them, family A and B shared the new region located in 2q36.1–
2q36.3, and the HLA-B locus was verified based on our original
single large pedigree family C with the maximum LOD score of
4.02 at marker D6S273. We initially proposed an affirmative
autosomal dominant inheritance in our three Han Chinese
pedigrees as one of the genetic modes in this complex and
genetically heterogeneous disease.
Brown et al conducted a genome scan in 1998 and revealed
nominal linkage with a LOD score of 0.8 at marker D2S126,
5
located in the region between D2S377 and D2S1349. Significant
LOD score was not achieved due to either insufficient genetic
information or heterogeneity between families. The studies
using individual case or sib-pair samples are more vulnerable to
the effects of heterogeneity. Therefore, the identification of
disease loci is better accomplished with family based linkage
studies. Herein, we approached this AS genome-wide scan
research in the Chinese population using a collection of
pedigrees with multiple affected individuals.
Previous genome-wide scans have suggested that the suscep-
tible locus of AS is in the HLA region. Strong associations with
HLA-B region have been identified by non-parametric linkage
Table 1 Multivariate logistic maximum likelihood estimates of segregation models for inheritance of
ankylosing spondylitis in family C
Multifactorial
only
Multifactorial+
commingled
Multifactorial+
Mendelian
Multifactorial+
free t’s
Multifactorial+
dominant
Multifactorial+
recessive
qA (1.0) 5.13610
23 0.68 0.84 0.70 0.97
tAA … … (1.0) 0.0 (1.0) (1.0)
tAB … … (0.5) 1.0 (0.5) (0.5)
tBB … … (0.0) 0.0 (0.0) (0.0)
SuscAA … 0 7.67610
230 7.36610
235 4.41610
222 8.49610
255
SuscAB … 0.14 7.61610
226 0 4.41610
222 0.50
SuscBB 0.17 0.14 0.51 0.54 0.56 0.50
rresid 1.67 8.08 4.00 4.02 4.06 3.87
-2lnL 47.16 32.15 26.38 22.36 26.44 28.13
Akaike’s AIC 51.16 42.15 36.38 32.36 34.44 36.12
Test H01: no major gene effect, x
2=20.78, df=3, p=1.17610
24.
Test H02: no transmission of major gene effect, x
2=9.79, df=3, p=0.02.
Test H03: Mendelian transmission, x
2=4.02, df=3, p=0.26.
Test H04: Mendelian transmission and dominant inheritance, x
2=0.06, df=1, p=0.81.
Test H05: Mendelian transmission and recessive inheritance, x
2=1.75, df=1, p=0.19.
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of HLA-B as the principal genetic determinant of AS has been
questioned and a handful of non-MHC loci have recently been
evaluated and proven to be associated with AS.
18 In our study,
we observe linkage to chromosome 6 which contains the HLA-B
locus in the genome-wide scan analysis and fine mapping of
family C with two-point LOD score .3. This result initially
confirmed linkage to the HLA-B region accompanied by a major
gene transmission with autosomal dominant inheritance in the
large pedigree of our study.
In conclusion, by parametric linkage analysis, we have
confirmed linkage to the HLA-B region in one AS pedigree and
reported a new locus in two AS pedigrees located on 2q36 for
the first time with autosomal dominant transmission.
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Figure 3 Scale map of the 13 fine mapping markers of pedigree A and
B. Scale map of markers on chromosome 2 for fine mapping of the
ankylosing spondylitis loci. Thirteen markers were selected from 2q35–
36.3 and one marker was used in the genome-wide scan. The distances
between markers were plotted according to sex averaged distances
determined with CEPH pedigree data.
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